Metastases Bone Disease
Metastases Bone Disease
Metastases Bone Disease
OT
Metastatic
Bone Disease
Introduction
The most common cause of destructive bone
lesions in the adult
The skeleton is the most common organ to be
affected by metastatic of cancer, and the site of
disease which produces the greatest morbidity
It is the third most common site
60% - 84% of all cases of metastatic disease invade bone
Primary tumors most likely to metastasize :
Breast (37 %)
Lung (15 %)
Prostate (15 %)
Kidney (6 %)
Thyroid (4 %)
Introduction
Definition
3 mechanisms:
-direct extension
-retrograde venous flow
-seeding with tumor emboli via the blood
circulation
Metastatic bone lesions: osteolytic,
osteoblastic and mixed
Osteolytic: destructive processes
Osteoblastic: new bone growth that is
stimulated by the tumour
Patophysiology
Tumor cells penetrating the surrounding
extracellular matrix
Neoangiogenesis
Primary Metastasis
Clinical presentation
Most skeletal mets are asymptomatic
discovered incidentally
diffuse bone pain (70%) periosteum
stretching
pathologic fracture (9,29%)common in
breast Ca
Pathologic fracture
Medical history
History related with the primary tumor (family
history, early manifestation of tumor, previous
tumor removal)
Breast tumor, Lung, Prostate, Kidney, Thyroid, etc
Pain
Progressive
Unrelenting night pain
Non-mechanical
Precipitated by minor trauma (irritation of nociceptor)
PLAIN RADIOGRAPHY
BONE SCAN
CT
CT-MYELOGRAPHY
MRI
Plain radiography
Pt. presented with pain in the right upper thigh, xray showing METS in
upper 1/3 of the femur, however radioisotope scan revealed many
deposits in other parts of the skeleton. Zaid Samkari 34
CT and CT myelography
CT Helpful in
defining bony integrity
CT-myelography
useful for patients who
cannot undergo MRI
MRI
Musculoskeletal Tumor
Chemotherapy Surgery
External Radiation
Internal Radiation
Systemic Controle
Preoperative; neoadjuvant
Objective
a. Downsize of staging
b. Facilitate of surgery (pseudocapsule)
c. Prevent micrometastatic
Posaoperative; adjuvant
Treatment:
• Can be divided into:
a) Systemic therapy, aimed at cancer cells that have
spread throughout the body, includes chemotherapy,
hormone therapy, and immunotherapy.
b) Local therapy, aimed at killing cancer cells in one
specific part of the body, includes radiation therapy
and surgery.
MEDICAL TREATMENT
Managing secondary
Chemotherapy
effect of tumor
• Effective in certain • Corticosteroid
types (primary • Biphosphonates
tumor: lymphoma • Analgesic agents
and
neuroblastoma)
• Used as adjuvant
or neoadjuvant
therapy
Managing secondary effect of
tumor
Analgesic
Corticosteroid Biphosphonates
agents
Primary adjuvant
Reduce spinal to reduce
osteolytic tumor
NSAID
cord edema
progression
Relieving local
pain (inhibiting
bone resorption)
RADIATION THERAPY
Reducing bone pain and
progression of tumour growth
90% will receive some relief
Complications: radiation
induced osteonecrosis &
theoretically may increase
rate of stress # or non-union
Indication: No risk for fracture
Recurrence of pain because of
biomechanical weakness
operative stabilisation
Treatment:
Surgery is indicated mainly in case of fractures or large
metastatic mass.
If bone destruction is extensive, resulting in imminent or
actual pathologic fracture we may need:
surgical fixation
resection and reconstruction
Surgical intervention provide stabilization and help minimize
morbidity
Primary aims of surgery
Relieve pain
Correction of deformity
Anterior Plate Fixation
TUMOR TUMOR
KELAINAN
METASTASIS PRIMER
Biasanya Biasanya
Jumlah lesi
multipel tunggal
Ukuran lesi Biasanya kecil Biasanya besar
Penyebaran
Jarang Sering
kista oseus
Realsi Terutama Terutama
osteoblas endosteal periosteal
PROGNOSIS
THANKS